History and actual problems of organ donation

G.I. Kovtun, B.M. Todurov, O.A. Kanyura

References

1. Bagnenko S.F., Reznik O.N. Key problems of the development of transplantology and the tasks of higher medical education. Transplantologiya. 2017. № 9(3). S. 192–210.
2. Carrel A. The transplantation of organs. New York Med J. 1914;99:839.
3. Voronoy YU.YU. Transplantation of a preserved cadaveric kidney as a method of biostimulation for severe nephritis. Vracheb. delo. 1950. № 9. S. 813–816.
4. Demikhov V.P. Selected works. M.: Vest', 2011. 257 s.
5. Glyantsev S.P. Trudno byt' geniyem. (K 100-letiyu so dnya rozhdeniya V.P. Demikhova). Khirurgiya. Zhurnal im. N.I. Pirogova. 2016. № 8. S. 94–99.
6. Istoriya transplantatsii pochki 2021. URL: https://oberig.ua/ru/news/statti/istoriya-transplantaciyi-nirki-660.
7. Khalelova D. Problemy transplantologii v sovremennoy meditsine. – 2012. Kazakhskiy med. zhurn. 2012. № 6 (30). S. 44–46. URL: https://www.heartcenter.kz/upload/iblock/7b4/7b4329f335205d403 abd916fc10 decd 2.pdf.
8. Ivanyushkin A.YA. Puti legitimizatsii kontseptsii smerti mozga: opyt Rossii i zarubezhnykh stran. Rabochiye tetradi po bioetike. Vyp. 19 / pod red. B.G. Yudina. M. : Izd-vo Mosk. gumanitarnogo un-ta, 2014. S. 29–58.
9. Barnard K.N. Human Heart Transplantation: A Preliminary Report on a Successful Operation Performed at Groote Schuur Hospital, Cape Town. S. Afr. Med. J. 1967;41(48):1271-1274.
10. Kaleda V.I. Christian Barnard (1922–2001) and his path to a heart transplant. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2017. T. 21, vyp. 3S. S. 92–100.
11. Sychev I. 50 let peresadok serdtsa. 2017. URL https://habr.com/ru/post/408763/
12. Dzheyms Khardi (khirurg). 2017. URL: https://hmn. wiki/ru/James _Hardy _ (surgeon).
13. Global observatory on donation and transplantation. Statistics by country and year. Available at: http://www.transplant-observatory. org/summary/ [Accessed July 3, 2020].
14. Yanushkevich K. V SSHA vpervyye transplantirovali polnost'yu iskusstvennoye serdtse. 2021. URL. https://trends.rbc.ru/trends /industry/ 60f808799 a79476b49eecdf6.
15. Ramel' Aksel'. Yevropeyskaya sistema donorstva i transplantatsii organov: tekushcheye polozheniye i perspektivy. 2016. URL: https://rm.coe.Int /16806b8199.
16. Newsletter Transplant. International Figures on donation and transplantation. EDQM, 2015/ https://rm.coe.int/16806b8199
17. Donor organ transplantation in the world in 2018 https://rustransplant.com/ chislo-transplantaciy-v-mire-uvelichilos/
18. Henderson ML, Gross JA. Living Organ Donation and Informed Consent in the United States: Strategies to Improve the Process. J of Law, Medicine & Ethics. 2017;54(1):66-7.
19. Mikhel' D.V., Reznik O.N. Defitsit organov kak global'naya problema: kul'turnyye razlichiya, neravenstva i al'ternativnyye strategii samoobespecheniya. Sotsio­­­gumanitarnyye problemy organnogo donorstva: mezhdistsiplinarnyye issledovaniya: sbornik nauchnykh statey / Pod red. O.N. Reznika. M., 2018. S. 11–58.
20. Mikhel' D.V. Razvitiye vysokotekhnologichnogo zdravookhraneniya v Yevrope: donorstvo i transplantatsiya organov / Yevropeyskaya bezopasnost': sobytiya, otsenki, tseni, prognozy. 2020. Vyp. 56 (72). C. 2–11. URL. https:// hromadske.ua/ru/posts/s-nachala-2021-goda-v-ukraine-proveli-48-operacij-po-transplantacii-organo.
21. Poznyakova N. Donorstvo organov v Yevrope: chto nemtsy khotyat sdelat' inache. 2018. https://www.dw.com/ru/donorstvo-organov-v-yevrope-chto-nemtsy-khotyat-sdelat'-inache/a-45367530.
22. Pinchuk A.V., Mukhametova M. Reformirovaniye organizatsionno-pravovoy sostavlyayushchey sistemy donorstva i transplantatsii SSHA s tsel'yu povysheniya yeye effektivnosti. Zdorov'ye megapolisa. 2020. T. 1, № 1. C. 96–101.
23. Henderson ML, et al. How Should Social Media Be Used in Transplantation? A Survey of the American Society of Transplant Surgeons. Transplantation. 2019;103(3):573-80.
24. International registry in organ donation and transplantation. USA 2019 statistics. Available at: https://www.irodat.org/?p=database&c=US&year =2019#data [Accessed July 3, 2020].
25. Organ Donation Statistics. U.S. Government Information on Organ Donation and Transplantation. Available at: https://www. organdonor.gov/statistics-stories/statistics.html [Accessed July 3, 2020].
26. Ispaniya – mirovoy lider po transplantatsii organov i tkaney. URL: http://notida.ru/allnews/ obshhestvo/ispaniya-mirovoj-lider-po-transplantadi-organov.htm.
27. Spain is among the world leaders in the field of transplantology. URL: https://espanarusa.com/ru/pedia/article/386042.
28. Peresadka serdtsa v Ispanii URL: https://alegria-medicine.com/blog/ medicine /heart-transplant-in-spain/.
29. Matesanz R, Dominguez-Gill B, Coll E, et al. Spanish experience as a leading country: what kind of measures were taken. Transplant international. 2011;24(4):333-43.
30. Transplantologiya v Ispanii. URL: https://bmc.cat/treatment-in- barcelona/ medical-specialties/transplantation/.
31. Donation after circulatory death and its expansion in Spain / E Miñambres, JJ Rubio, E Coll, B Domínguez-Gil. Current opinionin organ transplantation. 2018;23(1):120-9. https://doi.org/10.1097/MOT.0000000000000480.
32. Transplantatsiya donorskikh organov v mire v 2018 godu https://rustransplant.com/ chislo-transplantaciy-v-mire-uvelichilos/
33. Sanmartin OR. Spain creates the first transplant alliance with France and Italy. El Mundo. 2012. P. 16.
34. Vso o peresadke organov. Peresadka organov vo Frantsii. Elektronnyy resurs. URL:// https://medifrancesolution.com/ru/blog/vse-o-peresadke-organov/
35. Tsentr za tsentrom v Italii. Fonte: http://www.trapianti.salute.gov. it/ trapianti/ dettaglioContenutiCnt.jsp?lingua=italiano&area=cnt&menu=chiSiamo&id =242
36. Meditsina v Germanii. 2022. URL: https://ru.wikipedia.org/wiki
37. Germany Stataits Summary (2002-present). http://apps.who.int/gho/data/node.country.country-DEU?lang=en. Updated 2016. Accessed September 2nd, 2016.
38. Transplantation in Germany / B. Nashan et al. Transplantation. 2017; 101(2):212-8.
39. Zholkver N. Transplantatsiya organov: ogranicheniya v Germanii ostalis'. 2020. https://www.dw.com/ru/v-germanii-sokhranili-ogranicheniya-na-iz"yatiye-organov-u-posmertnykh-donorov/a-51999937.
40. Panasenko N. Vopros obyazatel'nogo donorstva organov raskolol Germaniyu. Rossiyskaya gazeta. 2019. 7 maya. Mode of access: URL: https://rg.ru/ 2019/05/07/donorstvo-organov.html (date of access – 20.12.2019).
41. Panasenko N. Vopros obyazatel'nogo donorstva organov raskolol Germaniyu. Rossiyskaya gazeta. 2019. 7 maya. Mode of access: URL: https://rg.ru/2019/05/07/donorstvo-organov.html (date of access – 20.12.2019).
42. Murphy PG, Smith M. Towards a framework for organ donation in the UK. Brit J Anaesthesia. 2012;108(1):i56-i67.
43. Presumed consent: the way forward for organ donation in the. 2017. UK. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363072/.
44. Transplantatsiya v Pol'she: yezhegodno okolo 500 operatsiy. URL:https://www.evromed.org.ua/transplantatsiya-organov-v-polshe/
45. Guzik-Makaruk EM, Olesiuk-Okomska M, Matuszkiewicz-Ro-wińska J, Małyszko J. Selected Legal Aspects of Donation After Circulatory Death in Poland. Ann of transplantation. 2019;24:93-9.https://doi.org/10.12659/AOT.912567.
46. A Summary of Transplantation 2019. https://pubmed.ncbi.nlm.nih. Gov /31101199/ ctivity in Hungary.
47. Ändringar i lag om organbevarande behandling 2022. https://www.socialstyrelsen.se/kunskapsstod-och-regler/omraden/organ-och-vavnadsdonation/andringar-i-lag-om-organbevarande-behandling/
48. Organ transplantation in the Czech Republic from 1966 to the present. https://English -radio-cz.translate.goog/organ-transplantation-czech-republic-1966-present-8603560.
49. Transplantologiya v klinikakh Indii URL: https://hospitals-travel.ru/countries /india/specialities/transplantology.
50. Transplantatsiya v Indii 2022. URL: https://www.topmedclinic.com/zabolevaniya/peresadka-organov,-tkm/transplantacziya-v-indii.html.
51. Transplantatsiya organov v Kitaye. 2020.URL: https://ru.wikipedia.org/wiki/.
52. Yan Dzh. i dr. Otnosheniye k donorstvu zhivykh organov i gotovnost' byt' zhivym donorom organov sredi grazhdan Kitaya v 3 gorodakh. Protsedury transplantatsii. 2018;50(10):3065-70.
53. Allison KC, et al. Historical development and current status of organ procurement from death-row prisoners in China. BMC Medical Ethics. 2015;16:85.
54. Sun Q, et al. A new era for organ transplantation in China. Lancet. 2014;383(9933):1971-2.
55. Lei Zhang, et al. Transformation of organ donation in China. Transplant International. 2015;28:410-5.
56. Akabayashi A, et al. Twenty Years After Enactment of the Organ Transplant Law in Japan: Why Are There Still So Few Deceased Donors? Transplantation Processing. 2018;50(5):1209-19.
57. Transplantatsiya (peresadka) organov v Belarusi URL: https://uamt.com. ua/RU/ "transplantatsiya-organov-v-belarusi.html.
58. V Belarusi za 12 let proveli 500 operatsiy po transplantatsii serdtsa. 2022. https://soyuz.by/obshchestvo/v-belarusi-za-12-let-proveli-500-operaciy-po-transplantacii-serdca.

Cognitive disorders in patients with atrial fibrillation

O.A. Yepanchintseva, A.S. Solonovych, O.S. Solonovych

References

1. Svyrydova NK, Parnikoza TP, Chupryna HM, Sulik RV, Lubenetsʹ HS, Inhula NI, Kravchuk NO. Algorithm prediction of cognitive impairment. Skhidno-yevropeysʹkyy nevrolohichnyy zhurnal. 2015; 3:28-38. Rezhym dostupu: http://nbuv.gov.ua/UJRN/cenj_2015_3_4.
2. Abed HS, Wittert GA, Leong DP et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: A randomized clinical trial. JAMA. 2013;310:2050–60. doi:10.1001/jama.2013.280521. 
3. Alonso A, Arenas de Larriva AP. Atrial Fibrillation, Cognitive Decline And Dementia. Eur Cardiol. 2016;11(1):49-53. doi:10.15420/ecr.2016:13:2. PMID: 27547248; PMCID: PMC4988519.
4. Bansal N, Zelnick LR, An J, et al. Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community-Based Population. J Am Heart Assoc. 2023;12(6):e028290. doi:10.1161/JAHA.122.028290. Epub 2023 Mar 8. PMID: 36883422; PMCID: PMC10111519.
5. Battistin U, AlQassim N, Hallak Y, et al. Cerebral Amyloid Angiopathy and Atrial Fibrillation: An up to Date Case Report. Neurohospitalist. 2022;12(2):391-394. doi:10.1177/19418744211067353. Epub 2022 Feb 11. PMID: 35419135; PMCID: PMC8995587.
6. Bunch TJ, Crandall BG, Weiss JP, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:839. DOI:10.1111/j.1540-8167.2011.02035.x.
7. Chao TF, Lip GYH, Liu CJ, et al. Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71:122. DOI:10.1016/j.jacc.2017.10.085.
8. Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;CD011145. doi:10.1002/14651858.CD011145.pub2
9. Dagres N, Chao TF, Fenelon G, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? J Arrhythm. 2018;34(2):99-123. doi:10.1002/joa3.12050. PMID: 29657586; PMCID: PMC5891416.
10. de Bruijn RFAG, Heeringa J, Wolters FJ, et al. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. 2015; 72:1288-94. doi:10.1001/jamaneurol.2015.2161.
11. Diener HC, Hart RG, Koudstaal PJ, Lane DA, Lip GYH. Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73(5):612-9. doi:10.1016/j.jacc.2018.10.077. PMID: 30732716.
12. Friberg L, Andersson T, Rosenqvist M. Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation. Eur Heart J. 2019;40:2327-35. doi:10.1093/eurheartj/ehz304.
13. Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. 2018;39:453. DOI:10.1093/eurheartj/ehx579.
14. Gallinoro E, D’Elia S, Prozzo D et al. Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? Medicina (Kaunas). 2019;13;55(9):587. doi:10.3390/medicina55090587. PMID: 31540311; PMCID: PMC6780629.
15. Gardarsdottir M, Sigurdsson S, Aspelund T, et al. Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion. Europace. 2018;20:1252-8. doi:10.1093/europace/eux220.
16. Haeusler KG, Wilson D, Fiebach JB, Kirchhof P, Werring DJ. Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives. Heart. 2014;100:1408-13. doi:10.1136/heartjnl-2013305151.
17. Hahne K, Mönnig G, Samol A. Atrial fibrillation and silent stroke: links, risks, and challenges. Vasc Health Risk Manag. 2016;12:65-74. doi:10.2147/VHRM.S81807.
18. Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circ J. 2015;79:495-502. doi:10.1253/circj.CJ-15-0138. 
19. Harrison JK, Noel-Storr AH, Demeyere N, Reynish EL, Quinn  TJ. Outcomes measures in a decade of dementia and mild cognitive impairment trials. Alzheimers Res Ther. 2016;8:48. doi:10.1186/s13195-016-0216-8.
20. Herm J, Schurig J, Martinek MR, et al. MRI-detected brain lesions in AF patients without further stroke risk factors undergoing ablation - a retrospective analysis of prospective studies. BMC Cardiovasc Disord. 2019;19(1):58. doi:10.1186/s12872-019-1035-1. PMID: 30871479; PMCID: PMC6419420.
21. Hsu JY, Liu PP, Liu AB, et al. Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study. J Am Heart Assoc. 2021;10(5):e016437. doi:10.1161/JAHA.120.016437. Epub 2021 Feb 15. PMID: 33586465; PMCID: PMC8174264.
22. Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiol. 2015;12:230-43. doi:10.1038/nrcardio.2015.2.
23. Jacobs V, Woller SC, Stevens S, et al. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm. 2014;11:2206. DOI:10.1016/j.hrthm.2014.08.013.
24. Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging. 2007;28:477-83. DOI:10.1016/j.neurobiolaging.2006.01.001.
25. Jefferson AL. Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis. 2010;20(3):813-21. doi:10.3233/JAD-2010-100081. PMID: 20413856; PMCID: PMC3041147.
26. Kalantarian S, Ay H, Gollub RL, et al. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis. Ann Intern Med. 2014;161(9):650-8. 
27. Kalantarian S, Ruskin JN. Atrial Fibrillation and Cognitive Decline. Cardiology Clinics. 2016;34(2):279-85 DOI:10.1016/j.ccl.2015.12.011.
28. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N-9N. DOI:10.1016/s0002-9149(98)00583-9
29. Knecht S, Oelschläger C, Duning T, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J. 2008;29(17):2125-32. doi:10.1093/eurheartj/ehn341.
30. Koh YH, Lew LZW, Franke KB, et al. Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals. Europace. 2022;24(8):1229-39. doi:10.1093/europace/euac003. PMID: 35061884; PMCID: PMC9435641.
31. Kozberg MG, Perosa V, Gurol ME, van Veluw SJ. A practical approach to the management of cerebral amyloid angiopathy. Int J Stroke. 2021;16(4):356-69. doi:10.1177/1747493020974464. Epub 2020 Nov 29. PMID: 33252026; PMCID: PMC9097498.
32. Krishnan K, Rossetti H, Hynan LS, et al. Changes in Montreal Cognitive Assessment scores over time. Assessment. 2017;24:772-7. doi:10.1177/1073191116654217.
33. Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76 (10):914-22. doi:10.1212/WNL.0b013e31820f2e38.
34. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4:752-9. doi:10.1016/S1474-4422(05)70221-0.
35. Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7(4):438-44. DOI:10.1016/j.hrthm.2009.12.009.
36. Li X, Yuan J, Yang L, et al. The significant effects of cerebral microbleeds on cognitive dysfunction: an updated meta-analysis. PLoS One. 2017;12:e0185145. doi:10.1371/journal.pone.0185145.
37. Madhavan M, Hu TY, Gersh BJ, et al. Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation. Mayo Clin Proc. 2018;93:145-54. doi:10.1016/j.mayocp.2017.09.021.
38. Madhavan M, Holmes DN, Piccini JP, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019;211:77-89. doi:10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30. PMID: 30901602.
39. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-25. doi:10.1161/CIRCULATIONAHA.105.595140.
40. O’Neal WT, Efird JT, Dawood FZ, et al. Coronary artery calcium and risk of atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2014;114:1707-12. DOI:10.1016/j.amjcard.2014.09.005.
41. Pathak RK, Middeldorp ME, Meredith M, et al. Long-term Effect of Goal directed weight management in an Atrial fibrillation Cohort: a long-term follow-up study (LEGACY Study). J Am Coll Cardiol. 2015;65:2159-69. doi:10.1016/j.jacc.2015.03.002. 
42. Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63-75.e2. doi:10.1016/j.jalz.2012.11.007.
43. Rivard L, Friberg L, Conen D et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022;145(5):392-409. doi:10.1161/CIRCULATIONAHA.121.055018.
44. Sachdev P, Kalaria R, O’Brien J, et al. International Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206-18. doi:10.1097/WAD.0000000000000034.
45. Saglietto A, Scarsoglio S, Ridolfi L, et al. Higher ventricular rate during atrial fibrillation relates to increased cerebral hypoperfusions and hypertensive events. Sci Rep. 2019;9:3779. doi:10.1038/s41598-019-40445-
46. Saito T, Kawamura Y, Sato N, et al. Non-vitamin K antagonist oral anticoagulants do not increase cerebral microbleeds. J Stroke Cerebrovasc Dis. 2015;24:1373-7. doi:10.1016/j.jstrokecerebrovasdis.2015.02.018.
47. Shi Y, Thrippleton MJ, Makin SD, et al. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016;36:1653-67. doi:10.1177/0271678X16662891.
48. Stefansdottir H, Arnar DO, Aspelund T, et al. Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts. Stroke. 2013;44(4):1020-5. doi:10.1161/STROKEAHA.12.679381. Epub 2013 Feb 26. PMID: 23444303; PMCID: PMC3632359.
49. Vergaro G, Aimo A, Rapezzi C, et al. Atrial amyloidosis: mechanisms and clinical manifestations. Eur J Heart Fail. 2022;24(11):2019-28. doi:10.1002/ejhf.2650. Epub 2022 Aug 21. PMID: 35920110; PMCID: PMC10087817.
50. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009;373:155-66. doi:10.1016/S0140-6736(09)60040-4.
51. Wersching H, Duning T, Lohmann H, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology. 2010;74:1022-9. DOI:10.1212/WNL.0b013e3181d7b45b.
52. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med. 1987;147:1561-4. PMID: 3632164.
53. Xia C, Vonder M, Sidorenkov G, et al. The relationship of coronary artery calcium and clinical coronary artery disease with cognitive function: a systematic review and meta-analysis. J Atheroscler Thromb. 2020;27:934-58. doi: 10.5551/jat.52928.
54. Zenger B, Rizzi S, Steinberg BA, et al. This is Your Brain, and This is Your Brain on Atrial Fibrillation: The Roles of Cardiac Malperfusion Events and Vascular Dysfunction in Cognitive Impairment. Arrhythm Electrophysiol Rev. 2023;12:e01. doi:10.15420/aer.2022.29. PMID: 36845168; PMCID: PMC9945461.

Predictors of cardiac conduction disorders in patients after aortic valve replacement

M.M. Zaretskyi, B.M. Todurov, O.M. Grytsay, V.B. Demyanchuk, O.V. Zelenchuk

References

1. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-8.
2. Auffret V, Puri R, Urena M, et al. Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives. Circulation. 2017;136(11):1049-69.
3. Bagur R, Manazzoni JM, Dumont E, et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis. Heart. 2011;97:1687-94.
4. Baird CW, Sefton B, Chávez M, et al. Congenital Aortic and Truncal Valve Reconstruction Utilizing the Ozaki Technique: Short term Clinical Results. J Thorac Cardiovasc Surg. 2021;161(5):1567-77.
5. Baraki H, Al Ahmad A, Jeng-Singh S, et al. Pacemaker dependency after isolated aortic valve replacement: do conductance disorders recover over time? Interact Cardiovasc Thorac Surg. 2013;16:476-81.
6. Baumgartner Н. Aortic stenosis: medical and surgical management. Heart. 2005;91(11):1483-8.
7. Christie GW. Anatomy of aortic heart valve leaflets: the influence of glutaraldehyde fixation on function. Eur J Cardio-Thoracic Surgery. 1992;6(1):25-32.
8. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105(3):146-52.
9. Dawkins S, Hobson AR, Kalra PR, et al. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg. 2008;85:108-12.
10. de Kerchove L, Jashari R, Boodhwani M, et al. Surgical anatomy of the aortic root: Implication for valve-sparing reimplantation and aortic valve annuloplasty. J Thoracic and Cardiovascular Surgery. 2015;149;425-33.
11. Ensminger S, Fujita B, Bauer T, et al. Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol. 2018;71(13):1417-28.
12. Erdogan HB, Kayalar N, Ardal H, et al. Risk factors for requirement of permanent pacemaker. J Card Surg. 2006;21:211-5.
13. Fujita B, Schmidt T, Bleiziffer S, et al. Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcom. Eur J Cardio-Thoracic Surg. 2020;57(1):151-9.
14. Greason KL, Lahr BD, Stulak JM, et al. Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement. Ann Thorac Surg. 2017;104:1259-64.
15. Huynh H, Dalloul G, Ghanbari H, et al. Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors. Pacing Clin Electrophysiol. 2009; 32:1520-5.
16. Hwang YM, Kim J, Lee JH, et al. Conduction disturbance after isolated surgical aortic valve replacement in degenerative aortic stenosis. J Thorac Cardiovasc Surg. 2017;154:1556-65.
17. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
18. Kawashima T, Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol. 2014;174(1):1-6.
19. Khatchatourov G, van Steenberghe M, Goy D, et al. Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases. JTCVS Open. 2021;26(8):193-202.
20. Koechlin L, Schurr U, Miazza J, et al. Echocardiographic and Clinical Follow-up After Aortic Valve Neocuspidization Using Autologous Pericardium. World J Surg. 2020;44(9):3175-81.
21. Koechlin L, Eckstein FS. Aortic Valve Neocuspidization Using Autologous Pericardium (Ozaki Procedure): an Alternative to Aortic Valve Replacement in Adult Cardiac Surgery? Current Anesthesiology Reports. 2021;11:318-25.
22. Kolesár A, Toporcer T, Kačer P, et al. The Role of Modification of the Original Ozaki Technique in the Treatment of Aortic Valve Diseases. Cor Vasa. 2020;62:547-50.
23. Kranе M, Boehm J, Prinzing A, Lange R. Approaching Mid-Term Results for Aortic Valve Reconstruction (Ozaki’s Procedure). Thorac Cardiovasc Surg. 2020;68(01);1-72.
24. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609-20.
25. Levac MM, Kapadia SR, Soltesz EG, et al. Prevalence of and Risk Factors for Permanent Pacemaker Implantation After Aortic Valve Replacement. Ann Thorac Surg. 2019;108:700-7.
26. Limongelli G, Ducceschi V, D’Andrea A, et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart. 2003;89:901-4.
27. Lopez A, Ahmad O, Guillot M, et al. World mortality in 2000: Life tables for 191 countries. Geneva: World Health Organization, 2002.
28. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–847.
29. Mylonas KS, Tasoudis PT, Pavlopoulos D, et al. Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data. Amer Heart J. 2023;255:1-11.
30. Nardi P, Pellegrino A, Scafuri A, et al. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, risk factors and surgical technical aspects. J Cardiovasc Med (Hagerstown). 2010;11:14-9.
31. O’Brien S, Shahian D, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac risk models: part 2 – isolated valve surgery. Ann. Thorac. Surg. 2009;88(1):23-42.
32. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002-12.
33. Ozaki S, Kawase I, Yamashita H, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12(4):550-3.
34. Ozaki S, Kawase I, Yamashita H, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014;147(1):301-6.
35. Pirola S, Mastroiacovo G, Arlati FG, et al. Single Center Five Years’ Experience of Ozaki Procedure: Midterm Follow-up. Ann Thorac Surg. 2021;111(6):1937-43.
36. Rene AG, Sastry A, Horowitz JM, et al. Recovery of atrioventricular conduction after pacemaker placement following cardiac valvular surgery. J Cardiovasc Electrophysiol. 2013;24:1383-7.
37. Ribeiro V, Garcia RM, Frutuoso С, et al. Permanent pacemaker implantation after aortic valve replacement: Long-term dependency or rhythm recovery? Rev Port Cardiol. 2015;34(9):529-33.
38. Robich MP, Schiltz NK, Johnston DR, et al. Risk factors and outcomes of patients requiring a permanent pacemaker after aortic valve replacement in the United States. J Card Surg. 2016;XX:1-10.
39. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statis- tics – 2012 update. A report from the American Heart Association. Circulation. 2012;125(1):e2–220.
40. Rubín JM, Avanzas P, del Valle R, et al. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv. 2011;4(3):280-6.
41. Sá MPBO, de Carvalho MMB, Sobral F, et al. Surgical aortic valve replacement and patient-prosthesis mismatch: a meta-analysis of 108 182 patients. Eur J Cardio-Thoracic Surg. 2019;56(1):44-54.
42. Schurr UP, Berli J, Berdajs D, et al. Incidence and risk factors for pacemaker implantation following aortic valve replacement. Interact Cardiovasc Thorac Surg. 2010;11:556-60.
43. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-98.
44. Song J, Liang Z, Wang Y, et al. Incidence of permanent pacemaker implantation after valve replacement surgery. Herz. 2021;46(1):109-14.
45. Tamburino C, Barbanti M, Capodanno D, et al. Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. Amer J Cardiol. 2012;109:1487-93.
46. Toggweiler S, Kobza R. Pacemaker implantation after transcatheter aortic valve: why is this still happening? J Thorac Dis. 2018;10(30):3614-9.
47. Tzamtzis S, Viquerat J, Yap J, et al. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys. 2013;35:125-30.
48. Urena M, Rodés-Cabau J. Permanent pacemaker implantation following transcatheter aortic valve replacement: still a concern? JACC Cardiovasc Interv. 2015;8:70-3.
49. Vahanian A, Andreotti OAF, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2012;33(19):2451-96.
50. Van Mieghem NM, Head SJ, de Jong W, et al. Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg. 2012;94:1143-9.

Clinical and hemodynamic characteristics of patients with intermediate coronary lesions selected for elective percutaneous coronary intervention

M.V. Stan, К.О. Mikhaliev, A.V. Khokhlov, O.J. Zharinov, B.M. Todurov

References

1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scienti­­fic Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. doi:10.1093/eurheartj/ehz425. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4242.
2. Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O’Connor RE, Ross MA, Shaw LJ. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28. Erratum in: Circulation. 2021;144(22):e455.
3. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394. Erratum in: Eur Heart J. 2019;40(37):3096.
4. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4-e17. doi:10.1161/CIR.0000000000001039. Epub 2021 Dec 9. Erratum in: Circulation. 2022;145(11):e771.
5. Boden WE, Marzilli M, Crea F, Mancini GBJ, Weintraub WS, Taqueti VR, Pepine CJ, Escaned J, Al-Lamee R, Gowdak LHW, Berry C, Kaski JC; Chronic Myocardial Ischemic Syndromes Task Force. Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;81(5):505-514. doi:10.1016/j.jacc.2022.08.814.
6. Boden W, Stone P. Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease. Annu Rev Med. 2023;74:189-98. doi:10.1146/annurev-med-042921-124013.
7. Gersh B, Bhatt D. To stent or not to stent? Treating angina after ISCHEMIA-the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease. Eur Heart J. 2021;42(14):1389-93. doi:10.1093/eurheartj/ehab069.001.
8. Boden W, Stone P. To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial. Eur Heart J. 2021;42(14):1394-1400. doi:10.1093/eurheartj/ehab069.002.
9. Kohsaka S, Ejiri K, Takagi H, Watanabe I, Gatate Y, Fukushima  K, Nakano S, Hirai T. Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease Following the ISCHEMIA Trial. JACC Asia. 2023;3(1):15-30. doi:10.1016/j.jacasi.2022.10.013.
10. Inohara T, Kohsaka S, Spertus JA, Masoudi FA, Rumsfeld JS, Kennedy KF, Wang TY, Yamaji K, Amano T, Nakamura M. Comparative Trends in Percutaneous Coronary Intervention in Japan and the United States, 2013 to 2017. J Am Coll Cardiol. 2020;76(11):1328-40. doi: 10.1016/j.jacc.2020.07.037.
11. Liu Y, Chen Y, Chang Z, Han Y, Tang S, Zhao Y, Fu J, Liu Y, Fan Z. Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis. J Cardiovasc Dev Dis. 2023;10(3):93. doi:10.3390/jcdd10030093.
12. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1-S127. doi:10.1016/j.kint.2022.06.008.
13. Fu EL, Coresh J, Grams ME, Clase CM, Elinder CG, Paik J, Ramspek CL, Inker LA, Levey AS, Dekker FW, Carrero JJ. Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population. Nephrol Dial Transplant. 2023;38(1):119-28. doi:10.1093/ndt/gfac197.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recom­­mendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. doi:10.1016/j.echo.2005.10.005.
15. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003.
16. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019;40(5):475.
17. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi:10.1093/eurheartj/ehab368.
18. Hussain ST, Paul M, Morton G, Schuster A, Chiribiri A, Perera D, Nagel E. Correlation of Fractional Flow Reserve With Ischemic Burden Measured by Cardiovascular Magnetic Resonance Perfusion Imaging. Am J Cardiol. 2017;120(11):1913-19. doi:10.1016/j.amjcard.2017.08.002.
19. Leone AM, De Caterina AR, Basile E, Gardi A, Laezza D, Mazzari MA, Mongiardo R, Kharbanda R, Cuculi F, Porto I, Niccoli G, Burzotta F, Trani C, Banning AP, Rebuzzi AG, Crea F. Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve. Circ Cardiovasc Interv. 2013;6(1):29-36. doi:10.1161/CIRCINTERVENTIONS.112.971101. Epub 2013 Jan 15.
20. Head SJ, Farooq V, Serruys PW, Kappetein AP. The SYNTAX score and its clinical implications. Heart. 2014;100(2):169-77. doi:10.1136/heartjnl-2012-302482. Epub 2013 Mar 28.
21. Ramanathan S, Al Heidous M, Alkuwari M. Coronary Artery Disease-Reporting and Data System (CAD-RADS): strengths and limitations. Clin Radiol. 2019;74(6):411-7. doi:10.1016/j.crad.2019.01.003. Epub 2019 Feb 11.
22. Peper J, Becker LM, van Kuijk JP, Leiner T, Swaans MJ. Fractional Flow Reserve: Patient Selection and Perspectives. Vasc Health Risk Manag. 2021;17:817-31. doi:10.2147/VHRM.S286916.
23. Scoccia A, Tomaniak M, Neleman T, Groenland FTW, Plantes ACZD, Daemen J. Angiography-Based Fractional Flow Reserve: State of the Art. Curr Cardiol Rep. 2022;24(6):667-78. doi:10.1007/s11886-022-01687-4. Epub 2022 Apr 18.
24. Achenbach S, Rudolph T, Rieber J, Eggebrecht H, Richardt G, Schmitz T, Werner N, Boenner F, Möllmann H. Performing and Interpreting Fractional Flow Reserve Measurements in Clinical Practice: An Expert Consensus Document. Interv Cardiol. 2017;12(2):97-109. doi:10.15420/icr.2017:13:2.
25. Гур’янов В.Г., Лях Ю.Є., Парій В.Д. та ін. Посібник з біостатистики. Аналіз результатів медичних досліджень у пакеті EZR (R-statistics): навч. посіб. Київ: Вістка, 2018. 207 с.
26. Verdoia M, Rognoni A. Coronary Physiology: Modern Concepts for the Guidance of Percutaneous Coronary Interventions and Medical Therapy. J Clin Med. 2023;12(6):2274. doi:10.3390/jcm12062274. 
27. Maznyczka AM, Matthews CJ, Blaxill JM, Greenwood JP, Mozid AM, Rossington JA, Veerasamy M, Wheatcroft SB, Curzen N, Bulluck H. Fractional Flow Reserve versus Angiography-Guided Management of Coronary Artery Disease: A Meta-Analysis of Contemporary Randomised Controlled Trials. J Clin Med. 2022;11(23):7092. doi:10.3390/jcm11237092.
28. Shabbir A, Travieso A, Mejía-Rentería H, Espejo-Paeres C, Gonzalo N, Banning AP, Serruys PW, Escaned J. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond. Interv Cardiol Clin. 2023;12(1):141-53. doi:10.1016/j.iccl.2022.09.012.

Long-term effectiveness of radiofrequency renal denervation in patients with resistant arterial hypertension (10-year follow-up results)

O.L. Rekovets, Yu.M. Sirenko, O.O. Torbas, S.M. Kushnir, G.F. Prymak

References

1. Dobrokhod H.S. Own Experience of Patient Selection for Renal Denervation. Arterialʹna hipertenziya. 2014. № 3. S. 45–48. DOI:10.22141/2224-1485.3.35.2014.82720.
2. Azizi M, Steichen O, Frank M, Bobrie G, Plouin PF, Sapoval M. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension. Eur J Vasc Endovasc Surg. 2012;43(3):293-9. doi: 10.1016/j.ejvs.2011.11.022. Epub 2012 Jan 9. PMID: 22237510.
3. Banegas JR, Messerli FH, Waeber B, Rodríguez-Artalejo F, de la Sierra A, Segura J, Roca-Cusachs A, Aranda P, Ruilope LM. Discrepancies between office and ambulatory blood pressure: clinical implications. Am J Med. 2009;122(12):1136-41. doi: 10.1016/j.amjmed.2009.05.020. PMID: 19958892.
4. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393-401. doi:10.1056/NEJMoa1402670. Epub 2014 Mar 29. PMID: 24678939.
5. Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O’Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64(11):1071-8. doi:10.1016/j.jacc.2014.05.012. Epub 2014 May 20. PMID: 24858423.
6. Böhm M, Linz D, Urban D, Mahfoud F, Ukena C. Renal sympathetic denervation: applications in hypertension and beyond. Nat Rev Cardiol. 2013;10(8):465-76. doi:10.1038/nrcardio.2013.89. Epub 2013 Jun 18. PMID: 23774592.
7. Böhm M, Linz D, Ukena C, Esler M, Mahfoud F. Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? Circ Res. 2014;115(3):400-9. doi:10.1161/CIRCRESAHA.115.302522. PMID: 25035133.
8. Burton RF. Estimating body surface area from mass and height: theory and the formula of Du Bois and Du Bois. Ann Hum Biol. 2008;35(2):170-84. doi:10.1080/03014460801908439. PMID: 18428011.
9. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-19. doi:10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7. PMID: 18391085.
10. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298(2):R245-53. doi:10.1152/ajpregu.00647.2009. Epub 2009 Dec 2. PMID: 19955493.
11. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046-58. doi:10.1161/CIRCULATIONAHA.111.030189. Epub 2011 Aug 8. PMID: 21824920; PMCID: PMC3210066.
12. Hayek SS, Abdou MH, Demoss BD, Legaspi JM, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Am J Hypertens. 2013;26(12):1452-8. doi:10.1093/ajh/hpt132. Epub 2013 Aug 9. PMID: 23934709.
13. Hansen JM, Abildgaard U, Fogh-Andersen N, Kanstrup IL, Bratholm P, Plum I, Strandgaard S. The transplanted human kidney does not achieve functional reinnervation. Clin Sci (Lond). 1994;87(1):13-20. doi:10.1042/cs0870013. PMID: 8062514.
14. Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocrinol Metab. 2014;18(4):502-4. doi:10.4103/2230-8210.137496. PMID: 25143906; PMCID: PMC4138905.
15. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275-81. doi:10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28. PMID: 19332353.
16. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C; European Society of Hypertension. Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention. 2013;9 Suppl R:R58-66. doi:10.4244/EIJV9SRA11. PMID: 23732157.
17. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60(2):419-24. doi:10.1161/HYPERTENSIONAHA.112.193870. Epub 2012 Jun 25. PMID: 22733462.
18. Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system. Hypertension. 2014;64(3):565-72. doi:10.1161/HYPERTENSIONAHA.114.03605. Epub 2014 Jun 16. PMID: 24935940.
19. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension. 2009;54(6):1195-201. doi:10.1161/HYPERTENSIONAHA.109.138610. Epub 2009 Oct 12. PMID: 19822798.
20. Schuck O, Marusova L, Lanska V. Moznosti vyuzití vzorce Cocrofta a Gaulta pro posouzení 24hodinového mocového vylucování elektrolytů [Use of the Cocroft and Gault formula for evaluation of 24-hour urinary excretion of electrolytes]. Bratisl Lek Listy. 1999;100(8):422-5. Czech. PMID: 10645029.
21. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-7. doi:10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14. PMID: 21403086.
22. Symplicity HTN-2 Investigators; Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903-9. doi:10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17. PMID: 21093036.
23. Stea F, Bozec E, Millasseau S, Khettab H, Boutouyrie P, Laurent S. Comparison of the Complior Analyse device with Sphygmocor and Complior SP for pulse wave velocity and central pressure assessment. J Hypertens. 2014;32(4):873-80. doi:10.1097/HJH.0000000000000091. PMID: 24509122.
24. Zhang Y, Zhang X, Liu L, Zanchetti A; FEVER Study Group. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J. 2011;32(12):1500-8. doi:10.1093/eurheartj/ehr039. Epub 2011 Feb 22. PMID: 21345850.
25. Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J. 2013;34(28):2132-40. doi:10.1093/eurheartj/eht197. Epub 2013 Jun 19. PMID: 23782649; PMCID: PMC3717311.

Experience of diagnosis and surgical treatment of cardiac myxomas

R.M. Vitovskyi, V.V. Isaіenko, A.R. Vitovskyi, O.A. Pishchurin,V.V. Grabarchuk, O.V. Satmari

References

1. Mkalaluh S, Szczechowicz M, et al. Surgical treatment of cardiac tumors: insights from an 18-year single-center analysis. Med Sci Monit. 2017;23:6201-9.
2. Vitovskiy R, Isaienko V, et al. The tactics of safe removal of heart myxomas; The experience of 796 operations. E J Cardiovasc Med. 2018;6(2):56-9. doi:10.15511/ejcm.18.00256.
3. Grubb KJ, Jevremovic V, Chedrawy EG. Mitral valve myxoma presenting with transient ischemic attack: a case report and review of the literature. J Med Case Rep. 2018;12:363. doi:10.1186/s13256-018-1920-8.
4. Dong-Soo Kim. A comprehensive perspective of clinical and echocardiographic features in the differential diagnosis of cardiac myxomas and myxoma-like masses. Korean Circ J. 2020;50(9):833-5. doi:10.4070/kcj.2020.0309.
5. Cianciulli TF, Cozzarin A, Soumoulou JB, Saccheri MC, Méndez RJ, Beck MA, Gagliardi JA, Lax J.A. Twenty years of clinical experience with cardiac myxomas: Diagnosis, treatment, and follow up. J Cardiovasc Imaging. 2019;27(1):37-47. doi:10.4250/jcvi.2019.27.e7.
6. Shi-Min Yuan, Song-Li Yan, and Ning Wu. Unusual aspects of cardiac myxoma. Anatol J Cardiol. 2017;17(3):241-7. doi:10.14744.
7. Ma G, Wang D, He Y, Zhang R, Zhou Y, Ying K. Pulmonary embolism as the initial manifestation of right atrial myxoma: a case report and review of the literature. Medicine (Baltimore). 2019;98(51):183-6.
8. Cresti A, Chiavarelli M, Glauber M, Tanganelli P, Scalese M, Cesareo F, et al. Incidence rate of primary cardiac tumors: a 14-year population study. J Cardiovasc Med (Hagerstown). 2016;17(1):37-43.

Analysis of the risk of early postoperative complications after Bentall procedure

V.A. Tymoshenko, B.M. Todurov

References

1. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax. 1968l;23(4):338-9. doi:10.1136/thx.23.4.338.
2. Li H, Song Y, Liu X, Yu H, Huang X, Feng X, Dong N, Wu L. Short-term outcomes of a novel modified Bentall procedure in acute type A aortic dissection. J Cardiovasc Surg (Torino). 2021;62(4):385-90. doi:10.23736/S0021-9509.21.11522-8.
3. Van HD, Pham TB, Chau CL, Vuong NL. Modified Bentall procedure: A 15-year single-center clinical experience. Asian Cardiovasc Thorac Ann. 2022;30(7):779-87. doi:10.1177/02184923221090692.
4. Dallan LRP, Dallan LAO, Duncan Santiago JA, Ribeiro Dias R, Manuel de Almeida Brandao C, Jatene FB. Bentall-de Bono procedure for acute aortic dissection. Multimed Man Cardiothorac Surg. 2021;2.2021. doi:10.1510/mmcts.2021.014.
5. Bortolotti U. Avoiding Bleeding in the Modified Bentall Procedure. Aorta (Stamford). 2021;9(2):92-3. doi:10.1055/s-0041-1725120.
6. Pan E, Kyto V, Savunen T, Gunn J. Early and late outcomes after open ascending aortic surgery: 47-year experience in a single centre. Heart Vessels. 2018;33:427-33.
7. Schaffer JM, Lingala B, Fischbein MP, Dake MD, Woo YJ, Mitchell RS, Miller DC. Midterm outcomes of open descending thoracic aortic repair in more than 5,000 medicare patients. Ann Thorac Surg. 2015;100:2087-94.
8. Zelenchuk O, Loskutov D, Timoshenko V, et al. Comparison of early postoperative outcomes after David and Bentall operations in a single center study. Azerbaijan Med J. 2022;2:89-94. doi:10.34921/amj.2022.2.014
9. Демянчук В.Б., Погребняк В.В., Зеленчук О.В. та ін. Оригінальний метод лікування аневризми висхідного відділу аорти. Кардіохірургія та інтервенційна кардіологія. 2020;4:29-33. doi:http://doi.org/10.31928/2305-3127-2020.4.2933 
10. Dunne B, Marr T, Andrews D, Larbalestier R, Edwards M, Merry C. Aortic root replacement for ascending aortic disease: a 10 year review. Heart Lung Circ. 2013;22:81-7.
11. Benke K, Agg B, Szabo L, Szilveszter B, Odler B, Polos M, Cao  C, Maurovich-Horvat P, Radovits T, Merkely B, Szabolcs Z. Bentall procedure: quarter century of clinical experiences of a single surgeon. J Cardiothorac Surg. 2016;11:19.
12. Ghotkar SV, Grayson AD, Fabri BM, Dihmis WC, Pullan DM. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg. 2006;1:14.
13. Giakoumidakis K, Baltopoulos GI, Charitos C, Patelarou E, Galanis P, Brokalaki H. Risk factors for prolonged stay in cardiac surgery intensive care units. Nurs Crit Care. 2011;16:243-51.
14. Wei Sheng, Hai-Qin Yang, Wei Han, et al. Predictors for prolonged stay in the intensive care unit after surgery for acute aortic dissection type A. Int J Clin Exp Med. 2019;12(4):4193-201

Early postoperative results after surgical aortic valve replacement concomitant with different methods of myocardial revascularization

K.S. Boyko, B.M. Todurov

References

1. Aleksandric S, Banovic M, Beleslin B. Challenges in Diagnosis and Functional Assessment of Coronary Artery Disease in Patients With Severe Aortic Stenosis. Front Cardiovasc Med. 2022;9:849032. doi:10.3389/fcvm.2022.849032.
2. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):e84-231. doi:10.1161/CIRCULATIONAHA.106.176857. Erratum in: Circulation. 2007 Apr 17;115(15):e409.
3. Lee R, Li S, Rankin JS, O’Brien SM, Gammie JS, Peterson ED, McCarthy PM, Edwards FH; Society of Thoracic Surgeons Adult Cardiac Surgical Database. Fifteen-year outcome trends for valve surgery in North America. Ann Thorac Surg. 2011;91(3):677-84; doi:10.1016/j.athoracsur.2010.11.009.
4. Dell’Amore A, Aquino TM, Pagliaro M, Lamarra M, Zussa C. Aortic valve replacement with and without combined coronary bypass grafts in very elderly patients: early and long-term results. Eur J Cardiothorac Surg. 2012;41(3):491-8. doi:10.1093/ejcts/ezr029. PMID: 22345174.
5. Ahmed OF, Al Kaabi LS, Kakamad FH, Mohammed SH, Salih RQ. Early outcome of combined coronary artery bypass grafting and valve surgery. Edorium J Cardiothorac Vasc Surg. 2018;5:100013C04OA2018.
6. Grau JB, Mak AW, Ferrari G, Johnson CK, Shaw RE, Sperling J, Brizzio ME, Zapolanski A. Perioperative predictors of midterm survival after aortic valve replacement. Asian Cardiovasc Thorac Ann. 2014;22(5):566-73. doi:10.1177/0218492313501509.
7. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, Bajaj N, Joseph L, Patel NS, Aksoy O, Stewart WJ, Griffin BP, Kapadia SR. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125(8):1005-13. doi:10.1161/CIRCULATIONAHA.111.039180.
8. Park S, Park SJ, Park DW. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease. Korean Circ J. 2023;53(3):113-33. doi:10.4070/kcj.2022.0333.
9. Bangalore S, Spertus JA, Stevens SR, Jones PG, Mancini GBJ, Leipsic J, Reynolds HR, Budoff MJ, Hague CJ, Min JK, Boden WE, O’Brien SM, Harrington RA, Berger JS, Senior R, Peteiro J, Pandit N, Bershtein L, de Belder MA, Szwed H, Doerr R, Monti L, Alfakih K, Hochman JS, Maron DJ; ISCHEMIA Research Group. Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. Circ Cardiovasc Interv. 2022;15(4):e010925. doi:10.1161/CIRCINTERVENTIONS.121.010925.
10. Alsidawi S, Khan S, Pislaru SV, Thaden JJ, El-Am EA, Scott CG, Morant K, Oguz D, Luis SA, Padang R, Lane CE, McCully RB, Pellikka PA, Oh JK, Nkomo VT. High Prevalence of Severe Aortic Stenosis in Low-Flow State Associated With Atrial Fibrillation. Circ Cardiovasc Imaging. 2021;14(7):e012453. doi:10.1161/CIRCIMAGING.120.012453.
11. Kuchulakanti P, Rha SW, Satler LF, Suddath WO, Pichard AD, Kent KM, Weissman NJ, Cheneau E, Pakala R, Canos DA, Pinnow EE, Waksman R. Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients. J Invasive Cardiol. 2004;16(12):688-91.
12. Alcalai R, Viola N, Mosseri M, Beeri R, Leibowitz D, Lotan C, Gilon D. The value of percutaneous coronary intervention in aortic valve stenosis with coronary artery disease. Am J Med. 2007;120(2):185.e7-13. doi:10.1016/j.amjmed.2005.07.008.
13. Wu J, Cong X, Lou Z, Zhang M. Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients. Front Cardiovasc Med. 2021;8:740084. doi:10.3389/fcvm.2021.740084.

Hybrid surgery for aneurysm of the arch and descending part of the aorta. Right-left subclavian bypass as a variant of subtotal debranching

O.V. Zelenchuk, A.V. Khokhlov, A.Yu. Shkandala, K.S. Boiko, O.Yu. Polishchuk, Z.V. Press, B.M. Todurov

References

1. Todurov B.M., Zelenchuk O.V., Sudakevych S.M., Shkandala A.YU. ta in. Ascending to descending aortic prosthesis with reimplantation of brachiocephalic vessels in aneurysm of the arch and descending aorta for hypoplasia of the arch and coarctation of the aorta. Kardiokhirurhiya ta interventsiyna kardiolohiya. 2020. № 2. S. 42–47.
2. Todurov B.M., Shkandala A.YU., Zelenchuk O.V., Rotarʹ M.F. ta in. Case of surgical treatment of ascending aorta and aortic arch aneurysm in a patient with unclassified connective tissue disease. Kardiokhirurhiya ta interventsiyna kardiolohiya. 2019. № 3. S. 46–50.
3. Shkandala A.YU., Todurov B.M., Furkalo S.M., Khokhlov A.V., Zelenchuk O.V.Thoracic endovascular aneurysm repair in patients with connective tissue disorders. Kardiokhirurhiya ta interventsiyna kardiolohiya. 2022. № 1–2. С. 18–27.
4. Ahmad W, Mylonas S, Majd P, Brunkwall JS. A current systematic evaluation and meta-analysis of chimney graft technology in aortic arch diseases. J Vasc Surg. 2017;66 (5):1602-10.
5. Alonso Pérez M, Llaneza Coto JM, Del Castro Madrazo JA, et al. Debranching aortic surgery. Thorac Dis. 2017;9(6):465-77.
6. Alsawas M, Zaiem F, Larrea-Mantilla L, et al. Effectiveness of surgical interventions for thoracic aortic aneurysms: A systematic review and meta-analysis. J Vasc Surg. 2017;66(4):1258-68.
7. Bakoyiannis C, Kalles V, Economopoulos K, et al. Hybrid techniques in the treatment of thoracoabdominal aortic aneurysms: systematic review. J Endovasc Ther. 2009;16:443.
8. Benedetto U, Melina G, Angeloni E, et al. Current results of open total arch replacement versus hybrid thoracic endovascular aortic repair for aortic arch aneurysm: a meta-analysis of comparative studies. J Thorac Cardiovasc Surg. 2013;145(1):305-6.
9. Borst HG, Walterbusch G, Schaps D. Extensive aortic replacement using «elephant trunk» prosthesis. Thorac Cardiovasc Surg. 1983;31:37-40.
10. Bosiers MJ, Donas KP, Mangialardi N, et al. European Multicenter Registry for the Performance of the Chimney/Snorkel Technique in the Treatment of Aortic Arch Pathologic Conditions. Ann Thorac Surg. 2016;101(6):2224-30. doi:10.1016/j.athoracsur.2015.10.112.
11. Cao P, De Rango P, Czerny M, et al. Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg. 2012;144(6):1286-300.
12. Chakos A, Jbara D, Yan TD, Tian DH. Long-term survival and related outcomes for hybrid versus traditional arch repair-a meta-analysis. Ann Cardiothorac Surg. 2018;7(3):319-27.
13. Chiesa R, Bertoglio L, Rinaldi E, Tshomba Y. Hybrid repair of aortic arch pathology. Multimed Man Cardiothorac Surg. 2014:mmu003.
14. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007;83:862-4.
15. Czerny M, Rylski B, Beyersdorf F. Thoracic endovascular aortic repair for uncomplicated type B aortic dissection. Curr Opin Cardiol. 2016;31(6):606-10.
16. De Rango P, Ferrer C, Coscarella C, et al. Contemporary comparison of aortic arch repair by endovascular and open surgical reconstructions. J Vasc Surg. 2015;61(2):339-46.
17. Drinkwater SL, Goebells A, Haydar A, et al. The incidence of spinal cord ischemia following thoracic and thoracoabdominal endovascular intervention. Eur J Vasc Endovasc Surg. 2010;40:729-35.
18. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ. ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873-926. https://doi.org/10.1093/eurheartj/ehu281.
19. Faulds J, Sandhu HK, Estrera AL, Safi HJ. Minimally Invasive Techniques for Total Aortic Arch Reconstruction. J. Methodist Debakey Cardiovasc. 2016;12(1):41-4.
20. Gopaldas RR, Dao TK, LeMaire SA, et al. Endovascular versus open repair of ruptured descending thoracic aortic aneurysms: a nationwide risk-adjusted study of 923 patients. J Thorac Cardiovasc Surg. 2011;142(5):1010-8.
21. Greenberg RK, Clair D, Srivastava S, et al. Should patients with challenging anatomy be offered endovascular aneurysm repair? J Vasc Surg. 2003;38(5):990-6.
22. Hiraoka A, Chikazawa G, Tamura K, et al. Clinical outcomes of different approaches to aortic arch disease. J Vasc Surg. 2015;61(1):88–95.
23. Hogendoorn W, Schlösser FJ, Moll FL, et al. Thoracic endovascular aortic repair with the chimney graft technique. J Vasc Surg. 2013;58(2):502-11.
24. Holt PJ, Johnson C, Hinchliffe RJ, et al. Outcomes of the endovascular management of aortic arch aneurysm: implications for management of the left subclavian artery. J Vasc Surg. 2010;51:1329-38.
25. Huang W, Ding H, Jiang M, et al. Outcomes Of Chimney Technique For Aortic Arch Diseases: A Single-Center Experience With 226 Cases. Clin Interv Aging. 2019;14:1829-40.
26. Jakob H, Tsagakis K, Pacini D, et al. The International E-vita Open Registry: data sets of 274 patients. J Cardiovasc Surg (Torino). 2011;52:717-23.
27. Joo HC, Youn YN, Ko YG, et al. Comparison of open surgical versus hybrid endovascular repair for descending thoracic aortic aneurysms with distal arch involvement. J Thorac Dis. 2018;10(6):3548-57.
28. Kang WC, YG Ko, Oh PC, et al. Comparison of Total Arch and Partial Arch Transposition During Hybrid Endovascular Repair for Aortic Arch Disease. Eur J Vasc Endovasc Surg. 2016:52(2):173-8.
29. Kawaharada N, Kurimoto Y, Ito T, et al. Hybrid treatment for aortic arch and proximal descending thoracic aneurysm: experience with stent grafting for second-stage elephant trunk repair. Eur J Cardiothorac Surg. 2009;(36):956-61.
30. Kopp R, Katada Y, Kondo S, et al. Multicenter analysis of endovascular aortic arch in situ stent-graft fenestrations for aortic arch pathologies. Ann Vasc Surg. 2019;59:36-47.
31. Lachat M, Mayer D, Criado FJ, et al. New technique to facilitate renal revascularization with use of telescoping self-expanding stent grafts: VORTEC. Vascular. 2008;16:69-72.
32. LeMaire SA, Carter SA, Coselli JS. The elephant trunk technique for staged repair of complex aneurysms of the entire thoracic aorta. Ann Thorac Surg. 2006;81(5):1561-9.
33. Leontyev S, Tsagakis K, Pacini D, et al. Impact of clinical factors and surgical techniques on early outcome of patients treated with frozen elephant trunk technique by using EVITA open stent-graft: results of a multicentre study. Eur J Cardiothorac Surg. 2016;49(2):660-6.
34. Lima B, Roselli EE, Soltesz EG, et al. Modified and «reverse» frozen elephant trunk repairs for extensive disease and complications after stent grafting. Ann Thorac Surg. 2012;93:103-9.
35. Milewski RK, Szeto WY, Pochettino A, et al. Have hybrid procedures replaced open aortic arch reconstruction in high-risk patients? A comparative study of elective open arch debranching with endovascular stent graft placement and conventional elective open total and distal aortic arch reconstruction. J Thorac Cardiovasc Surg. 2010;140(3):590-7.
36. Moll FL, Powell JT, Fraedrich G, Verzini F, et al. Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2011;41:S1eS58.
37. Moulakakis KG, Mylonas SN, Avgerinos E, et al. Hybrid open endovascular technique for aortic thoracoabdominal pathology. Circulation. 2011;124:2670.
38. Moulakakis KG, Mylonas SN, Markatis F, et al. A systematic review and meta-analysis of hybrid aortic arch replacement. Ann Cardiothorac Surg. 2013;2(3):247-60.
39. Moulakakis KG, Mylonas SN, Dalainas I, et al. The chimney-graft technique for preserving supraaortic branches: a review. Ann Cardiothorac Surg. 2013;2(3):339-46.
40. Nishi H, Mitsuno M, Tanaka H, et al. Spinal cord injury in patients undergoing total arch replacement: a cautionary note for use of the long elephant technique. J Thorac Cardiovasc Surg. 2011;142:1084-9.
41. Oderich GS, Gloviczki P, Farber M, et al. Abdominal debranching with aortic stent grafts for complex aortic aneurysms: preliminary results of the North American Complex Abdominal Aortic Debranching (NACAAD) Registry. Society for Vascular Surgery meeting; Chicago, IL; June 15-18, 2011.
42. Papakonstantinou NA, Antonopoulos CN , Baikoussis NG, et al. Aortic Arch Reconstruction: Are Hybrid Debranching Procedures a Good Choice? Heart Lung Circ. 2018;27(11):1335-49.
43. Patel HJ, Upchurch GR, Eliason JL, et al. Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair. Ann Thorac Surg. 2010;89;1475-81.
44. Pecoraro F, Lachat M, Cayne NS, et al. Mid-term results of chimney and periscope grafts in supraaortic branches in high risk patients. Eur J Vasc Endovasc Surg. 2017;54(3):295-302.
45. Parsa CJ, Williams JB, Bhattacharya SD, Wolfe WG, Daneshmand MA, McCann RL, et al. Midterm results with thoracic endovascular aortic repair for chronic type B aortic dissection with associated aneurysm. J Thorac Cardiovasc Surg. 2011;141:322-7. https://doi.org/10.1016/j.jtcvs.2010.10.043.
46. Privitera S. Simple shunting of thoracoabdominal aneurysms with visceral perfusion. The Annals of Thoracic Surgery. 2001;71(5):1753.
47. Quinones-Baldrich W, Jimenez JC, De Rubertis B, Moore WS. Combined endovascular and surgical approach (CESA) to thoracoabdominal aortic pathology: a 10-year experience. J Vasc Surg. 2009;49:1125-34.
48. Rango P. et al. Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg. 2012;144(6):1286-300.
49. Resch TA, Greenberg R, Lyden SP, et al. Combined staged procedures for the treatment of thoracoabdominal aneurysms. J Endovasc Ther. 2006;13:481-9.
50. Riambau V, Böckler D, Brunkwall J, Cao P, et al. Management of Descending Thoracic Aorta Diseases Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J VascEndovasc Surg. 2017;53:4e52. https://doi.org/10.1016/j.ejvs.2016.06.005.
51. Rigberg D. et al. Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: A statewide experience. J Vasc Surg. 2006;43(2):217-22.
52. Safi HJ, Estrera AL, Azizzadeh A, et al. Progress and future challenges in thoracoabdominal aortic aneurysm management. World J Surg. 2008;32:355-60.
53. Seike Y, Matsuda H, Fukuda T, et al. Total arch replacement versus debranching thoracic endovascular aortic repair for aortic arch aneurysm: what indicates a high-risk patient for arch repair in octogenarians? Gen Thorac Cardiovasc Surg. 2018;66(5):263-9.
54. Shahverdyan R. et al. Triple-barrel Graft as a Novel Strategy to Preserve Supra-aortic Branches in ArchTEVAR Procedures: Clinical Study and Systematic Review. Eur J Vasc and Endovasc Surg. 2013;45(1):28-35.
55. Shang T, Tian L, Li DL, et al. Favourable outcomes of endovascular total aortic arch repair via needle based in situ fenestration at a mean follow-up of 5.4 months. Eur J Vasc Endovasc Surg. 2018;55(3):369-76.
56. Sood V, Patel HJ, Williams DM, et al. Open and endovascular repair of the nontraumatic isolated aortic arch aneurysm. J Vasc Surg. 2014;60(1):57-63.
57. Steuer J, Eriksson MO, Nyman R, et al. Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection. Eur J Vasc Endovasc Surg. 2011;41(3);318-23.
58. Sun L, Qi R, Zhu J, Liu Y, et al. Total arch replacement combined with stented elephant trunk implantation: a new «standard» therapy for type a dissection involving repair of the aortic arch? Circulation. 2011;123:971-8.
59. Voskresensky I, Scali ST, Feezor RJ, et al. Outcomes of thoracic endovascular aortic repair using aortic arch chimney stents in high-risk patients. J Vasc Surg. 2017;66(1):9-20.
60. Zhang L, Zhao Z, Chen Y, et al. Reintervention after endovascular repair for aortic dissection: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2016;152(5):1279-88.
61. Zhu J, Dai X, Noiniyom P, et al. Fenestrated Thoracic Endovascular Aortic Repair Using Physician-Modified Stent Grafts (PMSGs) in Zone 0 and Zone 1 for Aortic Arch Diseases. Cardiovascular Intervent Radiol. 2019;42(1):19-27

A modified technique for reducing the duration of ischemic time of the heart and myocardial reperfusion in multivalve correction combined with coronary grafting

P.M. Semeniv

References

1. Ahmed OF, Al Kaabi LS, Kakamad FH, Mohammed SH, Salih RQ. Early outcome of combined coronary artery bypass grafting and valve surgery. Edorium J Cardiothorac Vasc Surg. 2018;5(1):100013C04OA2018. https://doi.org/10.5348/100013C04OA2018OA.
2. Loop FD, Higgins TL, Panda R, Pearce G, Estafanous FG. Myocardial protection during cardiac operations. Decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg. 1992;104(3):608-18. PMID: 1513150.
3. Trenkwalder T, Nelson CP, Musameh MD, Mordi IR, Kessler T, Pellegrini C, et al. Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis. Int J Cardiol. 2019;276:212-7. https://doi. org/10.1016/j.ijcard.2018.11.094.
4. Kim BJ, Kim YS, Kim HJ, Ju MH, Kim JB, Jung SH, Choo SJ, Chung CH. Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary Artery bypass grafting. J Thorac Dis. 2018;10(6):3632-42. https://doi.org/10.21037/jtd.2018.05.148.
5. Trummer G, Benk C, Beyersdorf   Controlled automated reperfusion of the whole body after cardiac arrest. J Thorac Dis. 2019;11(10):S1464-S1470. doi:10.21037/jtd.2019.04.05.
6. Okba F. Ahmed, Fahmi H. Kakamad, Saif S. Almudhaffar, Rafid Hameed Hachim, Kayhan A. Najar, Abdulwahid M. Salih, Dahat A. Hussen, Shvan H. Mohammed, Mohammed Q. Mustafa, Karukh K. Mohammed, Diyar A. Oma. Combined operation for coronary artery bypass grafting and mitral valve replacement; risk and outcome. Intern J Surgery Open. 2021;35.100393. doi.org/10.1016/j.ijso.2021.100393.
7. Agha RA, Sohrabi  C, Mathew G, Franchi  T, Kerwan  O’Neill N for the PROCESS Group The PROCESS 2020 guideline: updating consensus preferred reporting of CasE series in surgery (PROCESS) guidelines. Int J Surg. 2020;84:231-5. doi.org/10.1016/j.ijsu.2020.11.005.
8. Teng Z, Ma X, Zhang Q, Yun Y, Ma C, Hu S, Zou C. Additional mitral valve procedure and coronary artery bypass grafting versus isolated coronary artery bypass grafting in the management of significant functional ischemic mitral regurgitation: a meta-analysis. J Cardiovasc Surg (Torino). 2017;58(1):121-30. https://doi.org/10.23736/S0021- 9509.16.08852-2.

Medical marketing in healthcare institutions with public-private partnership mechanisms

А.V. Ivaniuk

References

1. Varnavskyy V. H. Derzhavno-pryvatne partnerstvo v okhoroni zdorov'ya: mizhnarodnyy dosvid / V. H. Varnavskyy // Upravlinnya okhoronoyu zdorov'ya. - 2012. - №1. - S. 9 - 16.
2. Kredisov A.I. Derzhavno - pryvatne partnerstvo: svitovyy dosvid i yoho vykorystannya v Ukrayini. / A.I. Kredisov, A.A. Bilous // Naukovyy zhurnal "Ekonomika Ukrayiny". - 2016. - №2 (643) .- S. 5-15.
3. Muzychenko A.S. Derzhavno-chastnoe partnerstvo yak instytut vzayemodiyi vlady ta biznesu. / A. S. Muzychenko, A. L. Berzhanir // Ekonomichnyy prostir: zb. nauk. pratsʹ. Dnipro: Vyd-vo PDABA, 2013. №. 75. S. 100-116.
4. Panova T.V. Dosvid rozvynenykh Yevropeysʹkykh krayin u vykorystanni form i modeley DPP v okhoroni zdorov'ya. / T.V.Panova // Pytannya ekonomiky i prava. M. 2015. № 11. Z 99-102
5. Ponyattya i sutnistʹ biznes-protsesiv v sferi marketynhu. [Elektronnyy resurs] Rezhym dostupu: https://spravochnick.ru/marketing/biznes-processy_marketinga_i_prodazh/.
6. Shcho take medychnyy marketynh. [Elektronnyy resurs] Rezhym dostupu: https: //imed.co.ua/ru/medicinskij-marketing/chto-takoe-medicinskij-marketing.
7. Enthoven A. What is an Integrated Health Care Financing and Delivery System (IDS / Health Econ Outcome Res. 2016. Open Access 2016 v.2: 115.
8. Keshvani P., Walsh A. Physician-Hospital Integration Strategies. Health Care Law Monthly December 2013. [Internet]. URL: https: //www.mcguirewoods. com / news-resources / publications / health_care / Physician-Hospital-Integration-Strategies.pdf. (Data zvernennya: 27.03.2021).

.

Wellens syndrome or For whom the bell tolls?

Yu.V. Savitska, A.I. Klantsa, N.V. Shchepina

References

1. Chen Y, Song K. Wellens’ syndrome: a life-saving diagnosis. Cardiovascular J Africa. 2019;30(4):e1-e3. doi:10.5830/CVJA-2019-010.
2. Coutinho Cruz M, Luiz I, Ferreira L, Cruz Ferreira R. Wellens’ Syndrome: A Bad Omen. Cardiology. 2017;137(2):100-3. https://doi.org/10.1159/000455911.
3. Kyaw K, Latt H, Aung S, Tun N, Phoo W, Yin H. Atypical Presentation of Acute Coronary Syndrome and Importance of Wellens’ Syndrome. Amer J Case Reports. 2018;19:199-202. doi:10.12659/ajcr.907992.
4. Marzlin K. Wellens Syndrome. AACN Advanced Critical Care. 2018;29(3):360-4. https://doi.org/10.4037/aacnacc2018289/
5. Mathew R, Zhang Y, Izzo C, Reddy P. Wellens’ Syndrome: A Sign of Impending Myocardial Infarction. Cureus. 2022;14(6):e26084. https://pubmed.ncbi.nlm.nih.gov/35747115/.
6. Miner B, Grigg W, Hart E. Wellens Syndrome. StatPearls Publishing [Internet]. – 2022. https://www.ncbi.nlm.nih.gov/books/NBK482490/#:~:text=Wellens%20syndrome%20describes%20an%20abnormal,normal%20or%20only%20slightly%20elevated.
7. Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018;40(2):87-165. https://doi.org/10.1093/eurheartj/ehy394.

.

Cristiaan Barnard. The Path to the Unknown (100th anniversary of birth)

V.B. Demyanchuk

References

1. Brink JG, Hassoulas J. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape town. Cardiovasc J Afr. 2009;20:31-5. https://hdl.handle.net/10520/EJC23200.
2. David Cooper. Christiaan Barnard: The Surgeon Who Dared Hardcover – Illustrated, Fonthill Media, 2017, 543 p.
3. Cooper DKC. Christiaan Barnard — The surgeon who dared: The story of the first human-to-human heart transplant. Global Cardiology Science and Practice 2018:11 рages. DOI: http://dx.doi.org/10.21542/gcsp.2018.11.

.